Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06110416 · ClinicalTrials.gov registry record · NA
Decreasing Post-Operative Nausea and Vomiting in the Bariatric Surgical Patient
A NA study, sponsored by Methodist Health System.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT06110416 is a NA study that has completed, run by Methodist Health System. The registered enrollment target is 50 participants.
The verdict
NCT06110416, a NA study, has completed, sponsored by Methodist Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
From the research and current studies, post-operative nausea and vomiting is a common complaint after bariatric surgery. Nausea relief inhalers could improve post-operative nausea and vomiting without the need for further medications, subsequently reducing the chance of side effects. This study could help improve patient satisfaction and increase the ability of the patient to ambulate after surgery with the use of a nausea relief inhaler.
Interventions
- OTHER nausea relief inhaler
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2020-12-23 |
| Est. Completion | 2023-06-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06110416
The ClinicalTrials.gov registry entry for NCT06110416 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Methodist Health System, which has 125 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which nausea relief inhaler is the first listed.
NCT06110416 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06110416 about?
NCT06110416 is a clinical study titled "Decreasing Post-Operative Nausea and Vomiting in the Bariatric Surgical Patient". From the research and current studies, post-operative nausea and vomiting is a common complaint after bariatric surgery. Nausea relief inhalers could improve post-operative nausea and vomiting without the need for further medications, subsequently reducing the chance of side effects. This study coul...
What is the current status of trial NCT06110416?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2020-12-23. Estimated completion is 2023-06-27.
What interventions are being tested in trial NCT06110416?
The interventions under investigation include: nausea relief inhaler (OTHER).
Who is sponsoring clinical trial NCT06110416?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.